Skip to main content

Home

  • Drug Development
    • Our Pipeline
    • Evaluation Pipeline
    • Therapeutic areas
    • Partnering
    • Useful Links
  • News
  • Investors
    • Regulatory News
    • AIM Rule 26
      • Annual and Half Yearly Reports
      • Admission Document & Articles
    • Shareholder communications
    • Investments Calculator
    • Share Alerts
    • Share Series
    • Share price look-up
    • Analyst Research
  • About us
    • Board of Directors and Management Team
    • Strategy and Vision
    • How we work
    • Working with us
    • Collaborative Pipeline
  • Contact us

News

Breadcrumb

  1. News
Category
Videos and audiocasts

ValiRx - Successful Evaluation of Triple Negative Breast Cancer Programme

15 Jul 2022
Events and presentations

Valirx - AGM & Live Q&A with Presentation Held on 30th June 2022.

1 Jul 2022
Videos and audiocasts

Valirx - Live Q&A Webinar With Presentation Held on 6th April 2022

6 Apr 2022
Articles

Valirx Recognised in the Biotechnology Awards 2022

5 Apr 2022
Videos and audiocasts

ValiRx update on proposed sub-license of VAL201

23 Mar 2022
Videos and audiocasts

Valirx - Growth & Innovation Forum Presentation 2022

11 Feb 2022
Videos and audiocasts

Valirx Signs Agreement with TheoremRX

5 Jan 2022
Videos and audiocasts

Valirx Amends License for VAL201 with Cancer Research Technology

20 Dec 2021
Videos and audiocasts

Valirx CEO, Dr Suzanne Dilly Presents at the LSE Investor Webinar

8 Dec 2021
Videos and audiocasts

Valirx - Live Q&A Webinar With Presentation Held on 25th November 2021

26 Nov 2021
Events and presentations

Midweek Takeaway with ValiRx CEO Suzy Dilly hosted By The Sunday Roast

4 Nov 2021
Events and presentations

Valirx CEO Suzanne Dilly talks to BRRMedia about today’s VAL201 announcement

2 Nov 2021
Events and presentations

Valirx's Suzanne Dilly's Sunday Roast Podcast with Zak Mir

18 Oct 2021
Articles

Life Science Innovation Article - Business & Industry UK

30 Sep 2021

Pagination

  • Current page 1
  • Page 2
  • Next page Next
  • Last page Last
ValiRx PLC

Contact us

ValiRx Plc
Eliot Park Innovation Centre
4 Barling Way
Nuneaton, CV10 7RH
UK

Tel: +44 (0)2476 796496
Email: info@valirx.com

Registered in England and Wales

Company Number: 3916791
VAT Number: 756 3180 24

UK Registered Office Address
Stonebridge House, Chelmsford Road, Hatfield Heath, England, CM22 7BD

Links

  • Drug Development
    • Our Pipeline
    • Evaluation Pipeline
    • Therapeutic areas
    • Partnering
    • Useful Links
  • News
  • Investors
    • Regulatory News
    • AIM Rule 26
      • Annual and Half Yearly Reports
      • Admission Document & Articles
    • Shareholder communications
    • Investments Calculator
    • Share Alerts
    • Share Series
    • Share price look-up
    • Analyst Research
  • About us
    • Board of Directors and Management Team
    • Strategy and Vision
    • How we work
    • Working with us
    • Collaborative Pipeline
  • Contact us
Terms and Conditions Privacy Policy Accessibility Compliance Corporate Governance Corporate Social Responsibility

Site and its contents Copyright © ValiRx PLC 2022. All rights reserved.
Website Design and Development by Sciad Communications Ltd